Microscopic Colitis: Evidence-Based Guide to Diagnosis and Management

Read full text
Authors: Sara Ghoneim, Michael G. Drage, Kristin E. Burke
Cited by: 1
References: 71

Abstract

Microscopic colitis (MC), which predominately affects older adults, is a chronic inflammatory bowel disease characterized by watery diarrhea. Diagnosis relies on histological examination, as there are no established biomarkers to facilitate noninvasive diagnosis, and endoscopic findings are typically unremarkable. MC is classified into subtypes of lymphocytic and collagenous colitis. First-line therapy is budesonide (9 mg/day for 6-8 weeks), which induces remission effectively. However, relapse rates are high, necessitating alternative treatment strategies. Long-term maintenance strategies include low-dose budesonide, bile salt binders, antidiarrheals, and advanced therapies for refractory cases.

Fields of Study & Subjects

Microscopic Colitis Inflammatory Bowel Disease Celiac Disease Research and Management

Publication details

Journal / source
Annual Review of Medicine
Publisher
Annual Reviews
Volume
77
Issue
1
Pages
253–266
Publication date
27 January 2026
Language
EN